Bastide Confirms Growth Momentum with 8.2% Organic Growth in the First Half

Strong Performance in the First Half

Bastide generated a half-year revenue of EUR 260.4 million, marking an increase of 8.0% in reported figures and 8.2% in organic growth. This performance reflects an acceleration in the second quarter, with the group posting a revenue of EUR 134.1 million, up by 8.0% and 8.1% organically. Home healthcare services, encompassing respiratory, nutrition-infusion-diabetes-stomatherapy activities, accounted for 60.9% of the half-year revenue. This segment displayed a solid organic growth of 7.9%, despite a 5% tariff reduction on sleep apnea services effective from April 1, 2025. The Home Maintenance activity saw a significant acceleration, with organic growth of 8.4% in the second quarter compared to 4.7% in the first quarter, driven by the dynamics of community-based activities.

Home Maintenance and International Expansion Drive Growth

Home Maintenance generated a half-year revenue of EUR 101.4 million, up by 6.5%. In community settings, growth reached 12.2% with a revenue of EUR 46.7 million, supported by exceptional contracts and rental activities. The retail and internet segment grew by 2.1% to EUR 54.7 million. The Respiratory activity continued its excellent momentum with EUR 85.9 million, achieving an organic growth of 11.0% (10.4% in reported figures, affected by currency fluctuations). Internationally, organic growth was 21.0%, boosted by a new contract in British Columbia, Canada, and the performance of Oxystore in Italy. The Nutrition-Infusion-Diabetes-Stomatherapy activity reported EUR 73.0 million, up by 7.2%. Bastide confirms its revenue target of at least EUR 510 million for the fiscal year 2025-2026, with an operating margin maintained around 9.0%. The group aims for a net debt to EBITDA ratio below 3.0 by December 31, 2025.